Interchangeabilité des biomédicaments: différences conceptuelles, impacts compétitifs ?

Francis Megerlin ()
Additional contact information
Francis Megerlin: CEIE - Centre d'études internationales et européennes - UNISTRA - Université de Strasbourg

Post-Print from HAL

Date: 2021-01-16
References: Add references at CitEc
Citations:

Published in Séminaire Agence nationale des produits pharmaceutiques, ANPP, Ministère de l'industrie pharmaceutique, Jan 2021, Alger (en ligne), Algeria

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-04376535

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().